Publicaciones en las que colabora con Manuel Antonio Arias Rodríguez (16)

2013

  1. Once-monthly pegylated epoetin beta versus darbepoetin alfa every two weeks in renal transplant recipients: A randomized Trial

    Transplantation

2012

  1. Everolimus as primary immunosuppression in kidney transplantation: Experience in conversion from calcineurin inhibitors

    Transplantation, Vol. 93, Núm. 4, pp. 398-405

2011

  1. Erratum: Estimation of renal allograft half-life: Fact or fiction? (Nephrology Dialysis Transplantation (2011) 26 (30133018) DOI 10.1093/ndt/gfq788)

    Nephrology Dialysis Transplantation

2010

  1. Comparative analysis of adverse events requiring suspension of mTOR inhibitors: Everolimus versus sirolimus

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 3050-3052

  2. Long-term graft function changes in kidney transplant recipients

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

2009

  1. A novel risk score for mortality in renal transplant recipients beyond the first posttransplant year

    Transplantation, Vol. 88, Núm. 6, pp. 803-809

2008

  1. Improved renal function, with similar proteinuria, after two years of early tacrolimus withdrawal from a regimen of sirolimus plus tacrolimus

    Transplantation, Vol. 86, Núm. 4, pp. 620-622

2007

  1. Early Sirolimus Use With Cyclosporine Elimination Does Not Induce Progressive Proteinuria

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2151-2152

  2. Evaluation of the Efficacy and Safety of the Conversion From a Calcineurin Inhibitor to an Everolimus-Based Therapy in Maintenance Renal Transplant Patients

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2148-2150

2006

  1. Conversion to Everolimus in Kidney Transplant Recipients: A Safe and Simple Procedure

    Transplantation Proceedings, Vol. 38, Núm. 8, pp. 2424-2426

  2. Conversión a sirolimus

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 52-63

  3. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction

    Nephrology Dialysis Transplantation, Vol. 21, Núm. 11, pp. 3252-3257

  4. Manejo de sirolimus en la práctica clínica

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 64-93

  5. Uso de sirolimus en el paciente «De Novo»

    Nefrologia, Vol. 26, Núm. SUPPL.2, pp. 33-51

2005

  1. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: A multicenter study

    Transplantation Proceedings

2001

  1. Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine

    Transplantation Proceedings